The efficacy and toxicity of afatinib in advanced EGFR-positive non-small-cell lung cancer patients after failure of first-generation tyrosine kinase inhibitors: a systematic review and meta-analysis

DOI Web Site 1 Citations

Journal

Citations (1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top